Skip to main content
. 2001 Oct 23;2001(4):CD003159. doi: 10.1002/14651858.CD003159

Amaducci 1999.

Methods multinational, multicentre, double blind, randomized, placebo controlled, parallel groups
Participants SDAT mild to moderate; 24 patients received nicergoline, 24 placebo; 
 age > 50 yr.
Interventions Nicergoline or Placebo 30mg. twice a day (os) for 12 months
Outcomes ADAScog, IADL, CGIC for efficacy; adverse events for safety
Notes CGIC data were not available. ITT (LOCF) analysis is available